Form 4 for CL Colgate-Palmolive
Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-12 · accession 0001225208-25-005095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-14 | 2025-05-12 | CL | Newman Brian | Dir | A - Grant | $0.00 | +2,019 | 4,621 | +78% | $0 |
| D | 2025-05-14 | 2025-05-12 | CL | Newman Brian | Dir | A - Grant | $0.00 | +2,272 | 2,272 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-12 | A | A | 2,019 | $0.00 | 4,621 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-05-12 | A | A | 2,272 | $0.00 | 2,272 | D | $89.14 · — to 2033-05-12 | 2,272 Common Stock | (F3) Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 12, 2025 grant date. |